Showing results (1201-1210 of 1,284) with videos related to
Sort By:
Pageof 129
Blood Cancer Journal|April 11, 2015
Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell developmentE N Smith, E M Ghia, C M DeBoever, et al.Scientific Reports|February 13, 2021
Patterns and processes of pathogen exposure in gray wolves across North AmericaEllen E Brandell, Paul C Cross, Meggan E Craft, et al.The New England Journal of Medicine|March 5, 2020
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 SuppressionSusan Swindells, Jaime-Federico Andrade-Villanueva, Gary J Richmond, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer SusceptibilityNardin Samuel, Gavin Wilson, Mathieu Lemire, et al.Nature Biotechnology|April 12, 2016
Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseasesRong Chen, Lisong Shi, Jörg Hakenberg, et al.Nature Genetics|October 5, 2001
A radiation hybrid map of mouse genesT J Hudson, D M Church, S Greenaway, et al.Journal of Translational Medicine|April 19, 2015
GLI2 inhibition abrogates human leukemia stem cell dormancyAnil Sadarangani, Gabriel Pineda, Kathleen M Lennon, et al.Lancet (London, England)|December 14, 2020
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority studyEdgar T Overton, Gary Richmond, Giuliano Rizzardini, et al.Nature|February 14, 2014
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemiaLiran I Shlush, Sasan Zandi, Amanda Mitchell, et al.Scientific Reports|June 17, 2022
Association between germline variants and somatic mutations in colorectal cancerRichard Barfield, Conghui Qu, Robert S Steinfelder, et al.Pageof 129